YOD1 and Alzheimer disease: As the all-round phenotypic improvements that we observed in the HD model upon Yod1 overexpression were not characteristic for the AD model we concluded that the effects of Yod1 are rather specific to mHtt-induced pathology than having a generic positive effect in response to accumulation of misfolded proteins.